Everolimus (SoVarGen)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameEverolimus (SoVarGen)
Drug Alias NameSVG101SVG-101
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionmTOR Complex 2 inhibitorsMammalian target of Rapamycin (mTORC1) inhibitors
TargetsmTOR Complex 2Mammalian target of Rapamycin (mTORC1)
Therapy Area/IndicationsSeizures
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSoVarGen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSoVarGen Co Ltd
Inactive CompaniesN/A
Active IndicationsSeizures
Inactive IndicationsN/A

Other Information

ATC CodeL01EG02
Related LinksWikipediaDrugBankKEGG